newsfilter
← Latest News
GlobeNewswire·

Trillium Therapeutics Announces $25 Million Equity Investment From Pfizer Inc.

Pfizer invests $25 million in Trillium common shares at $10.88 per shareJeff Settleman, PhD, Pfizer’s Chief Scientific Officer for Oncology Research & Development, to join Trillium Scientific...